Scout | Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)

This grant opportunity aims to support the development of new brain stimulation devices or the improvement of existing ones for treating mental health disorders. Applicants should develop either novel devices with advanced stimulation techniques beyond current electrical/magnetic methods, or significantly enhance current FDA-approved devices in terms of spatial resolution, delivery depth, and …

Source

Agency: National Institutes of Health

Sub-agency: National Institute of Mental Health

Program: SBIR

Award

Award Ceiling: $200,000

Funding Amount: $200,000

Dates

Opportunity Released: October 12, 2021

Open for Submission: October 12, 2021

Submission Deadline: January 7, 2025

Application Window Closes: January 7, 2025

Keywords

brain stimulation

mental health disorders

novel medical devices

FDA-approved devices

spatiotemporal precision

multi-focal stimulation

closed-loop systems

systems neuroscience

engineering in medicine

regulatory affairs

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers